• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

培养的正常人肝细胞不合成脂蛋白相关凝血抑制剂:内皮是其合成主要部位的证据。

Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis.

作者信息

Bajaj M S, Kuppuswamy M N, Saito H, Spitzer S G, Bajaj S P

机构信息

Department of Medicine, Saint Louis University School of Medicine, MO 63104.

出版信息

Proc Natl Acad Sci U S A. 1990 Nov;87(22):8869-73. doi: 10.1073/pnas.87.22.8869.

DOI:10.1073/pnas.87.22.8869
PMID:2247459
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC55061/
Abstract

Human plasma contains a factor Xa-dependent inhibitor of tissue factor/factor VIIa complex termed lipoprotein-associated coagulation inhibitor (LACI). The present study examines the site(s) of LACI synthesis. In this study, cultured hepatocytes isolated from normal human liver were found to be essentially negative in LACI mRNA as revealed by Northern blot analysis using a full-length LACI cDNA as probe. The conditioned media from these cultures were also essentially negative for LACI activity. Similarly, poly(A)+ RNA obtained from normal human liver did not contain detectable LACI mRNA. In contrast, cultured human umbilical vein endothelial cells and human lung tissue (rich in endothelium) both contained abundant amounts of LACI mRNA. Moreover, erythrocyte lysates and culture media from normal monocytes, lymphocytes, or neutrophils did not contain measurable LACI activity; these cells were also negative for LACI mRNA. Platelets, however, contained LACI activity. The likely source of platelet LACI is the megakaryocyte cell since a megakaryocyte cell line (MEG-01) was found to contain LACI mRNA and to secrete small amounts of LACI activity. Additionally, human vascular smooth muscle cells and lung fibroblasts were also found to synthesize only small amounts of LACI. From these observations, we conclude that normal liver does not synthesize LACI and that endothelium is the principal source of plasma LACI. The undegraded LACI synthesized by endothelial cells had a molecular weight of approximately 41,000.

摘要

人血浆中含有一种组织因子/因子VIIa复合物的Xa因子依赖性抑制剂,称为脂蛋白相关凝血抑制剂(LACI)。本研究检测了LACI的合成部位。在本研究中,使用全长LACI cDNA作为探针进行Northern印迹分析发现,从正常人肝脏分离的培养肝细胞的LACI mRNA基本呈阴性。这些培养物的条件培养基的LACI活性也基本为阴性。同样,从正常人肝脏获得的poly(A)+ RNA也未检测到LACI mRNA。相比之下,培养的人脐静脉内皮细胞和人肺组织(富含内皮)均含有大量的LACI mRNA。此外,正常单核细胞、淋巴细胞或中性粒细胞的红细胞裂解物和培养基中均未检测到可测量的LACI活性;这些细胞的LACI mRNA也呈阴性。然而,血小板含有LACI活性。血小板LACI的可能来源是巨核细胞,因为发现一种巨核细胞系(MEG-01)含有LACI mRNA并分泌少量LACI活性。此外,还发现人血管平滑肌细胞和肺成纤维细胞仅合成少量LACI。根据这些观察结果,我们得出结论,正常肝脏不合成LACI,内皮是血浆LACI的主要来源。内皮细胞合成的未降解LACI的分子量约为41,000。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37f0/55061/a434173ef3d4/pnas01047-0195-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37f0/55061/c9dd055f9139/pnas01047-0194-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37f0/55061/06a631583980/pnas01047-0194-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37f0/55061/a434173ef3d4/pnas01047-0195-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37f0/55061/c9dd055f9139/pnas01047-0194-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37f0/55061/06a631583980/pnas01047-0194-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37f0/55061/a434173ef3d4/pnas01047-0195-a.jpg

相似文献

1
Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis.培养的正常人肝细胞不合成脂蛋白相关凝血抑制剂:内皮是其合成主要部位的证据。
Proc Natl Acad Sci U S A. 1990 Nov;87(22):8869-73. doi: 10.1073/pnas.87.22.8869.
2
Identification of the 1.4 kb and 4.0 kb messages for the lipoprotein associated coagulation inhibitor and expression of the encoded protein.脂蛋白相关凝血抑制剂1.4 kb和4.0 kb信使核糖核酸的鉴定及编码蛋白的表达。
Thromb Res. 1989 Jul 1;55(1):37-50. doi: 10.1016/0049-3848(89)90454-4.
3
Expression of tissue factor pathway inhibitor by cultured endothelial cells in response to inflammatory mediators.培养的内皮细胞对炎症介质反应时组织因子途径抑制物的表达
Blood. 1992 Jun 15;79(12):3219-26.
4
Endogenous phosphorylation of the lipoprotein-associated coagulation inhibitor at serine-2.脂蛋白相关凝血抑制剂丝氨酸-2位点的内源性磷酸化
Biochem J. 1990 Sep 15;270(3):621-5. doi: 10.1042/bj2700621.
5
The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action.抑制因子VII-组织因子复合物的脂蛋白相关凝血抑制剂也能抑制因子Xa:对其可能作用机制的深入了解。
Blood. 1988 Feb;71(2):335-43.
6
The lipoprotein-associated coagulation inhibitor.脂蛋白相关凝血抑制剂。
Prog Hemost Thromb. 1991;10:243-68.
7
Immunoaffinity purification and characterization of lipoprotein-associated coagulation inhibitors from Hep G2 hepatoma, Chang liver, and SK hepatoma cells. A comparative study.从Hep G2肝癌细胞、Chang肝细胞和SK肝癌细胞中免疫亲和纯化及鉴定脂蛋白相关凝血抑制剂。一项比较研究。
J Biol Chem. 1990 Sep 25;265(27):16096-101.
8
Inhibition of factor VIIa-tissue factor coagulation activity by a hybrid protein.一种杂合蛋白对因子VIIa-组织因子凝血活性的抑制作用。
Science. 1990 Jun 15;248(4961):1421-4. doi: 10.1126/science.1972598.
9
Purification and characterization of the lipoprotein-associated coagulation inhibitor from human plasma.人血浆中脂蛋白相关凝血抑制剂的纯化与特性研究
J Biol Chem. 1989 Nov 5;264(31):18832-7.
10
Structure of the human lipoprotein-associated coagulation inhibitor gene. Intro/exon gene organization and localization of the gene to chromosome 2.人类脂蛋白相关凝血抑制剂基因的结构。基因的内含子/外显子组织以及该基因在2号染色体上的定位。
J Biol Chem. 1991 Mar 15;266(8):5036-41.

引用本文的文献

1
The Tissue Factor Pathway in Cancer: Overview and Role of Heparan Sulfate Proteoglycans.癌症中的组织因子途径:硫酸乙酰肝素蛋白聚糖的概述及作用
Cancers (Basel). 2023 Feb 28;15(5):1524. doi: 10.3390/cancers15051524.
2
Lipoprotein(a) in Atherosclerotic Diseases: From Pathophysiology to Diagnosis and Treatment.脂蛋白(a)在动脉粥样硬化疾病中的作用:从病理生理学到诊断与治疗。
Molecules. 2023 Jan 18;28(3):969. doi: 10.3390/molecules28030969.
3
Haemostasis and Inflammatory Parameters as Potential Diagnostic Biomarkers for VTE in Trauma-Immobilized Patients.

本文引用的文献

1
Isolation and culture of adult hepatocytes from liver biopsies.从肝脏活检组织中分离和培养成人肝细胞。
In Vitro. 1981 Nov;17(11):935-40. doi: 10.1007/BF02618417.
2
7-Ethoxycoumarin deethylase activity as a convenient measure of liver drug metabolizing enzymes: regulation in cultured rat hepatocytes.
Biochem Pharmacol. 1984 May 1;33(9):1537-46. doi: 10.1016/0006-2952(84)90425-8.
3
Isolation and culture of human intestinal smooth muscle cells.人肠道平滑肌细胞的分离与培养。
止血和炎症参数作为创伤固定患者静脉血栓栓塞症潜在的诊断生物标志物
Diagnostics (Basel). 2023 Jan 2;13(1):150. doi: 10.3390/diagnostics13010150.
4
ZNF354C Mediated by DNMT1 Ameliorates Lung Ischemia-Reperfusion Oxidative Stress Injury by Reducing TFPI Promoter Methylation to Upregulate TFPI.DNMT1 介导的 ZNF354C 通过减少 TFPI 启动子甲基化来上调 TFPI,从而减轻肺缺血再灌注氧化应激损伤。
Oxid Med Cell Longev. 2022 Jul 19;2022:7288729. doi: 10.1155/2022/7288729. eCollection 2022.
5
Cirrhosis and Coagulopathy: Mechanisms of Hemostasis Changes in Liver Failure and Their Management.肝硬化与凝血功能障碍:肝衰竭时止血变化的机制及其管理
Cureus. 2022 Apr 3;14(4):e23785. doi: 10.7759/cureus.23785. eCollection 2022 Apr.
6
The Impact of Anticoagulant Activity of Tissue Factor Pathway Inhibitor Measured by a Novel Functional Assay for Predicting Deep Venous Thrombosis in Trauma Patients: A Prospective Nested Case-Control Study.新型组织因子途径抑制剂功能测定对预测创伤患者深静脉血栓形成的抗凝活性的影响:一项前瞻性巢式病例对照研究。
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211063877. doi: 10.1177/10760296211063877.
7
Knockdown screening of chromatin binding and regulatory proteins in zebrafish identified Suz12b as a regulator of tfpia and an antithrombotic drug target.在斑马鱼中对染色质结合和调节蛋白进行的敲低筛选鉴定 Suz12b 为 tfpia 的调节剂和抗血栓药物靶点。
Sci Rep. 2021 Jul 27;11(1):15238. doi: 10.1038/s41598-021-94715-2.
8
The contribution of TFPIα to the hemostatic response to injury in mice.TFPIα 对小鼠损伤止血反应的贡献。
J Thromb Haemost. 2021 Sep;19(9):2182-2192. doi: 10.1111/jth.15430. Epub 2021 Jul 14.
9
Major Reservoir for Heparin-Releasable TFPIα (Tissue Factor Pathway Inhibitor α) Is Extracellular Matrix.肝素释放型 TFPIα(组织因子途径抑制物 α)的主要储存库是细胞外基质。
Arterioscler Thromb Vasc Biol. 2021 Jun;41(6):1942-1955. doi: 10.1161/ATVBAHA.120.315728. Epub 2021 Apr 8.
10
SARS-CoV-2 suppresses anticoagulant and fibrinolytic gene expression in the lung.SARS-CoV-2 抑制肺部的抗凝和纤维蛋白溶解基因表达。
Elife. 2021 Mar 8;10:e64330. doi: 10.7554/eLife.64330.
Proc Soc Exp Biol Med. 1984 Sep;176(4):503-7. doi: 10.3181/00379727-176-4-rc1.
4
Cytochemical identification of monocytes and granulocytes.单核细胞和粒细胞的细胞化学鉴定。
Am J Clin Pathol. 1971 Mar;55(3):283-90. doi: 10.1093/ajcp/55.3.283.
5
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.在噬菌体T4头部组装过程中结构蛋白的切割
Nature. 1970 Aug 15;227(5259):680-5. doi: 10.1038/227680a0.
6
Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria.源自脐静脉的人内皮细胞培养。通过形态学和免疫学标准进行鉴定。
J Clin Invest. 1973 Nov;52(11):2745-56. doi: 10.1172/JCI107470.
7
Preparation of suspensions of washed platelets from humans.人洗涤血小板悬液的制备。
Br J Haematol. 1972 Feb;22(2):193-204. doi: 10.1111/j.1365-2141.1972.tb08800.x.
8
Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.从人血中分离单核细胞和粒细胞。通过一次离心分离单核细胞,通过离心和1g沉降相结合的方法分离粒细胞。
Scand J Clin Lab Invest Suppl. 1968;97:77-89.
9
Inhibition of tissue factor/factor VIIa activity in plasma requires factor X and an additional plasma component.
Blood. 1985 Jul;66(1):204-12.
10
The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action.抑制因子VII-组织因子复合物的脂蛋白相关凝血抑制剂也能抑制因子Xa:对其可能作用机制的深入了解。
Blood. 1988 Feb;71(2):335-43.